Alternative Complement Pathway Deficiency Ameliorates Chronic Smoke-Induced Functional and Morphological Ocular Injury

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Woodell, Alex ^a   Coughlin, Beth ^a   Kunchithapautham, Kannan ^a   Casey, Sarah ^a   Williamson, Tucker ^a   Ferrell, W Drew ^b   Atkinson, Carl ^a   Jones, Bryan W ^b   Rohrer, Bärbel ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; OPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRUCH MEMBRANE; CELL LOSS; CELLULAR DISTRIBUTION; CHOROID; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; ELECTRORETINOGRAPHY; GENE EXPRESSION; GENOTYPE; LONG TERM EXPOSURE; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PROTEIN LOCALIZATION; RETINA CONE; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD; SMOKE;

ANIMALS; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; EYE DISEASES; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; LECTINS; MALE; MICE; MITOCHONDRIA; SIGNAL TRANSDUCTION; SMOKE; TIME FACTORS; TOBACCO;

ANIMALIA; MUS;

EID: 84879386286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067894     Document Type: Article

References (93)

1. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, et al. (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120: 844-851.
2. Freund KB, Zweifel SA, Engelbert M, (2010) Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30: 1333-1349.
3. Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, et al. (2005) Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol 40: 277-287.
4. Edwards AO, Ritter R, 3rd, Abel KJ, Manning A, Panhuysen C, et al (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
5. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
6. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
7. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
8. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38: 458-462.
9. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
10. Johnson LV, Leitner WP, Staples MK, Anderson DH, (2001) Complement activation and inflammatory processes in drusen formation and age-related macular degeneration. Exp Eye Res 73: 887-896.
11. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29: 95-112.
12. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, et al. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20: 705-732.
13. Ferreira VP, Pangburn MK, Cortes C, (2010) Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 47: 2187-2197.
14. Droz I, Mantel I, Ambresin A, Faouzi M, Schorderet DF, et al. (2008) Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. Br J Ophthalmol 92: 513-517.
15. Seddon JM, Reynolds R, Rosner B, (2009) Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies. Invest Ophthalmol Vis Sci 50: 586-591.
16. Montes T, Tortajada A, Morgan BP, Rodriguez de Cordoba S, Harris CL, (2009) Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc Natl Acad Sci U S A 106: 4366-4371.
17. Mantel I, Ambresin A, Moetteli L, Droz I, Roduit R, et al. (2013) Complement factor B polymorphism and the phenotype of early age-related macular degeneration. Ophthalmic Genet (Epub ahead of print).
18. Muller-Eberhard HJ, (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57: 321-347.
19. Harboe M, Garred P, Borgen MS, Stahl GL, Roos A, et al. (2006) Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Clin Exp Immunol 144: 512-520.
20. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE, (2004) The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 138: 439-446.
21. Thurman JM, Ljubanovic D, Royer PA, Kraus DM, Molina H, et al. (2006) Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest 116: 357-368.
22. Yang P, Tyrrell J, Han I, Jaffe GJ, (2009) Expression and modulation of RPE cell membrane complement regulatory proteins. Invest Ophthalmol Vis Sci 50: 3473-3481.
23. Yin W, Ghebrehiwet B, Weksler B, Peerschke EI, (2008) Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress. Thromb Res 122: 221-228.
24. Lois N, Abdelkader E, Reglitz K, Garden C, Ayres JG, (2008) Environmental tobacco smoke exposure and eye disease. Br J Ophthalmol 92: 1304-1310.
25. Chakravarthy U, Augood C, Bentham GC, de Jong PT, Rahu M, et al. (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114: 1157-1163.
26. Mitchell P, Wang JJ, Smith W, Leeder SR, (2002) Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 120: 1357-1363.
27. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, et al. (2006) Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90: 75-80.
28. Church DF, Pryor WA, (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126.
29. Alberg A, (2002) The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180: 121-137.
30. Bruno RS, Traber MG, (2006) Vitamin E biokinetics, oxidative stress and cigarette smoking. Pathophysiology 13: 143-149.
31. Chow CK, Thacker RR, Changchit C, Bridges RB, Rehm SR, et al. (1986) Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J Am Coll Nutr 5: 305-312.
32. Panda K, Chattopadhyay R, Ghosh MK, Chattopadhyay DJ, Chatterjee IB, (1999) Vitamin C prevents cigarette smoke induced oxidative damage of proteins and increased proteolysis. Free Radic Biol Med 27: 1064-1079.
33. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, et al. (2003) Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med 35: 1582-1588.
34. van der Vaart H, Postma DS, Timens W, ten Hacken NH, (2004) Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59: 713-721.
35. Kew RR, Ghebrehiwet B, Janoff A, (1985) Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest 75: 1000-1007.
36. Zhu BQ, Parmley WW, (1995) Hemodynamic and vascular effects of active and passive smoking. Am Heart J 130: 1270-1275.
37. Friedman E, (2004) Update of the vascular model of AMD. Br J Ophthalmol 88: 161-163.
38. Fujihara M, Nagai N, Sussan TE, Biswal S, Handa JT, (2008) Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS One 3: e3119.
39. Wang AL, Lukas TJ, Yuan M, Du N, Handa JT, et al. (2009) Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration. PLoS One 4: e5304.
40. Jia L, Liu Z, Sun L, Miller SS, Ames BN, et al. (2007) Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci 48: 339-348.
41. Bertram KM, Baglole CJ, Phipps RP, Libby RT, (2009) Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration. Am J Physiol Cell Physiol 297: C1200-1210.
42. Espinosa-Heidmann DG, Suner IJ, Catanuto P, Hernandez EP, Marin-Castano ME, et al. (2006) Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci 47: 729-737.
43. Matsumoto M, Fukuda W, Circolo A, Goellner J, Strauss-Schoenberger J, et al. (1997) Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci U S A 94: 8720-8725.
44. Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, et al. (2009) A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci 50: 3056-3064.
45. Gresh J, Goletz PW, Crouch RK, Rohrer B, (2003) Structure-function analysis of rods and cones in juvenile, adult, and aged C57bl/6 and Balb/c mice. Vis Neurosci 20: 211-220.
46. Prusky GT, Alam NM, Beekman S, Douglas RM, (2004) Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci 45: 4611-4616.
47. Lohr HR, Kuntchithapautham K, Sharma AK, Rohrer B, (2006) Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death. Exp Eye Res 83: 380-389.
48. Marc RE, Liu W, (2000) Fundamental GABAergic amacrine cell circuitries in the retina: nested feedback, concatenated inhibition, and axosomatic synapses. J Comp Neurol 425: 560-582.
49. Anderson JR, Jones BW, Yang JH, Shaw MV, Watt CB, et al. (2009) A computational framework for ultrastructural mapping of neural circuitry. PLoS Biol 7: e1000074.
50. Stoppelkamp S, Riedel G, Platt B, (2010) Culturing conditions determine neuronal and glial excitability. J Neurosci Methods 194: 132-138.
51. Atkinson C, He S, Morris K, Qiao F, Casey S, et al. (2010) Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation. J Immunol 185: 7007-7013.
52. Liu CH, Lin CH, Tsai MJ, Chen WT, Chai CY, et al. (2012) Melanin bleaching with dilute hydrogen peroxide: A simple and rapid method. Appl Immunohistochem Mol Morphol (Epub ahead of print).
53. Guymer R, Luthert P, Bird A, (1999) Changes in Bruch's membrane and related structures with age. Prog Retin Eye Res 18: 59-90.
54. Hiscott P, Sheridan C, Magee RM, Grierson I, (1999) Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 18: 167-190.
55. Mettu PS, Wielgus AR, Ong SS, Cousins SW, (2012) Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration. Mol Aspects Med 33: 376-398.
56. Owsley C, McGwin G, Jackson GR, Heimburger DC, Piyathilake CJ, et al. (2006) Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Invest Ophthalmol Vis Sci 47: 1310-1318.
57. Zhang H, Fan J, Li S, Karan S, Rohrer B, et al. (2008) Trafficking of membrane-associated proteins to cone photoreceptor outer segments requires the chromophore 11-cis-retinal. J Neurosci 28: 4008-4014.
58. Pugh ENJ, Falsini B, Lyubarsky AL (1998) The origin of the major rod- and cone-driven components of the rodent electroretinogram and the effect of age and light-rearing history on the magnitude of these components. In: Photostasis and Related Phenomena; Williams TP, Thistle AB, New York: Plenum Press. 93-128.
59. Franco LM, Zulliger R, Wolf-Schnurrbusch UE, Katagiri Y, Kaplan HJ, et al. (2009) Decreased visual function after patchy loss of retinal pigment epithelium induced by low-dose sodium iodate. Invest Ophthalmol Vis Sci 50: 4004-4010.
60. McGill TJ, Prusky GT, Douglas RM, Yasumura D, Matthes MT, et al. (2007) Intraocular CNTF reduces vision in normal rats in a dose-dependent manner. Invest Ophthalmol Vis Sci 48: 5756-5766.
61. Thomas BB, Shi D, Khine K, Kim LA, Sadda SR, (2010) Modulatory influence of stimulus parameters on optokinetic head-tracking response. Neurosci Lett 479: 92-96.
62. Pu M, Xu L, Zhang H, (2006) Visual response properties of retinal ganglion cells in the royal college of surgeons dystrophic rat. Invest Ophthalmol Vis Sci 47: 3579-3585.
63. Cronin VB, Doyle JM, Doonan S, (1990) Amino acid sequences of aspartate aminotransferases: the cytosolic isoenzymes from yeast and from human liver. Biochem Soc Trans 18: 256.
64. Masayesva BG, Mambo E, Taylor RJ, Goloubeva OG, Zhou S, et al. (2006) Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev 15: 19-24.
65. Spaide RF, Curcio CA, (2011) Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 31: 1609-1619.
66. Burke JM, Zareba M, (2009) Sublethal photic stress and the motility of RPE phagosomes and melanosomes. Invest Ophthalmol Vis Sci 50: 1940-1947.
67. Huang JD, Presley JB, Chimento MF, Curcio CA, Johnson M, (2007) Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. Exp Eye Res 85: 202-218.
68. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, et al. (2009) Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 50: 4982-4991.
69. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, et al. (1995) Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 102: 640-646.
70. Chen JC, Fitzke FW, Pauleikhoff D, Bird AC, (1992) Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci 33: 334-340.
71. Marshall J, Hussain AA, Starita C, Moore DJ, L PA (1998) Ageing and Bruch's membrane. In: The Retinal Pigment Epithelium: Function and Disease; Marmor MF, Wolfensberger TJ, New York: Oxford University Press. 669-692.
72. Cankova Z, Huang JD, Kruth HS, Johnson M, (2011) Passage of low-density lipoproteins through Bruch's membrane and choroid. Exp Eye Res 93: 947-955.
73. Brown B, Adams AJ, Coletta NJ, Haegerstrom-Portnoy G, (1986) Dark adaptation in age-related maculopathy. Ophthalmic Physiol Opt 6: 81-84.
74. Brown B, Tobin C, Roche N, Wolanowski A, (1986) Cone adaptation in age-related maculopathy. Am J Optom Physiol Opt 63: 450-454.
75. Curcio CA, (2001) Photoreceptor topography in ageing and age-related maculopathy. Eye (Lond) 15: 376-383.
76. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, et al. (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78: 852-864.
77. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL, 3rd, et al (2005) Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112: 533-539.
78. Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, et al. (1995) Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 270: 18825-18830.
79. Liles MR, Newsome DA, Oliver PD, (1991) Antioxidant enzymes in the aging human retinal pigment epithelium. Arch Ophthalmol 109: 1285-1288.
80. Tate DJ Jr, Oliver PD, Miceli MV, Stern R, Shuster S, et al. (1993) Age-dependent change in the hyaluronic acid content of the human chorioretinal complex. Arch Ophthalmol 111: 963-967.
81. Hecker LA, Edwards AO, (2010) Genetic control of complement activation in humans and age related macular degeneration. Adv Exp Med Biol 703: 49-62.
82. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, et al. (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16: 1392-1403.
83. Sanai M, Hussain N, (2011) Levels of inflammatory markers (complement C3, complement C4 and C-reactive protein) in smokers. AfrJ Biotechnol 10: 19211-19217.
84. Lyubarsky AL, Savchenko AB, Morocco SB, Daniele LL, Redmond TM, et al. (2005) Mole quantity of RPE65 and its productivity in the generation of 11-cis-retinal from retinyl esters in the living mouse eye. Biochemistry 44: 9880-9888.
85. Pappuru RR, Ouyang Y, Nittala MG, Hemmati HD, Keane PA, et al. (2011) Relationship between outer retinal thickness substructures and visual acuity in eyes with dry age-related macular degeneration. Invest Ophthalmol Vis Sci 52: 6743-6748.
86. Barot M, Gokulgandhi MR, Mitra AK, (2011) Mitochondrial dysfunction in retinal diseases. Curr Eye Res 36: 1069-1077.
87. Jarrett SG, Lin H, Godley BF, Boulton ME, (2008) Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res 27: 596-607.
88. Feher J, Kovacs I, Artico M, Cavallotti C, Papale A, et al. (2006) Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol Aging 27: 983-993.
89. He Y, Tombran-Tink J, (2010) Mitochondrial decay and impairment of antioxidant defenses in aging RPE cells. Adv Exp Med Biol 664: 165-183.
90. Kondoh H, (2008) Cellular life span and the Warburg effect. Exp Cell Res 314: 1923-1928.
91. Sheng ZH, Cai Q, (2012) Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13: 77-93.
92. Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, et al. (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478: 76-81.
93. Shaw PX, Zhang L, Zhang M, Du H, Zhao L, et al. (2012) Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A 109: 13757-13762.